Skip to nav Skip to content

Clinical Trial Search

366 Clinical Trials Found

Clinical Trial 21112

Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma
Disease Site: Melanoma, skin
PI: Eroglu, Zeynep

Clinical Trial 20641

A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma
Disease Site: Melanoma, skin
PI: Eroglu, Zeynep

Clinical Trial 23454

Disease Site: Soft Tissue
PI: Gaballa, Sameh

Clinical Trial 23563

A Phase 1b trial of Teclistamab in Combination with Iberdomide for Relapsed/Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
PI: Grajales-Cruz, Ariel

Clinical Trial 23556

A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS)
PI: Lancet, Jeffrey

Clinical Trial 23641

Disease Site: Unknown Sites
PI: Pidala, Joseph

Clinical Trial 23581

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Tarlatamab in Combination with YL201 with or without Anti-PD-L1 in Subjects with Extensive Stage Small Cell Lung Cancer
Disease Site: Lung
PI: Puri, Sonam

Clinical Trial 23624

A Phase 1/2 Open-label Study to Investigate the Safety of Sonrotoclax Ramp-up Schedule(s) in Adult Patients With Hematological Malignancies
Disease Site: Soft Tissue
PI: Zhang, Yumeng

Clinical Trial 23659

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Disease Site: Any Site, Cervix, Colon, Corpus Uteri, Lung, Other Female Genital, Pancreas, Rectum
PI: Kim, Richard

Clinical Trial 21192

A Phase 2 Study of the Combination Dostarlimab with Niraparib In Patients with Penile Carcinoma Who Have Progressed Following Chemotherapy
Disease Site: Other Male Genital
PI: Chadha, Juskaran

Clinical Trial 22617

Disease Site: Breast
PI: Soyano Muller, Aixa

Clinical Trial 22102

A Phase 1b, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants with Solid Tumors
Disease Site: Breast, Other Female Genital, Ovary
PI: Han, Heather